Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2009 3
2010 1
2011 2
2013 2
2014 4
2015 4
2016 3
2017 6
2018 4
2019 4
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.
Villar J, Ferrando C, Martínez D, Ambrós A, Muñoz T, Soler JA, Aguilar G, Alba F, González-Higueras E, Conesa LA, Martín-Rodríguez C, Díaz-Domínguez FJ, Serna-Grande P, Rivas R, Ferreres J, Belda J, Capilla L, Tallet A, Añón JM, Fernández RL, González-Martín JM; dexamethasone in ARDS network. Villar J, et al. Among authors: ferreres j. Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7. Lancet Respir Med. 2020. PMID: 32043986 Clinical Trial.
Reconnection to mechanical ventilation for 1 h after a successful spontaneous breathing trial reduces reintubation in critically ill patients: a multicenter randomized controlled trial.
Fernandez MM, González-Castro A, Magret M, Bouza MT, Ibañez M, García C, Balerdi B, Mas A, Arauzo V, Añón JM, Ruiz F, Ferreres J, Tomás R, Alabert M, Tizón AI, Altaba S, Llamas N, Fernandez R. Fernandez MM, et al. Among authors: ferreres j. Intensive Care Med. 2017 Nov;43(11):1660-1667. doi: 10.1007/s00134-017-4911-0. Epub 2017 Sep 22. Intensive Care Med. 2017. PMID: 28936675 Clinical Trial.
Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial.
Villar J, Añón JM, Ferrando C, Aguilar G, Muñoz T, Ferreres J, Ambrós A, Aldecoa C, Suárez-Sipmann F, Thorpe KE, Jüni P, Slutsky AS; DEXA-COVID19 Network. Villar J, et al. Among authors: ferreres j. Trials. 2020 Aug 16;21(1):717. doi: 10.1186/s13063-020-04643-1. Trials. 2020. PMID: 32799933 Free PMC article.
Ceftolozane Pharmacokinetics in a Septic Critically Ill Patient under Different Extracorporeal Replacement Therapies.
Carbonell N, Aguilar G, Ferriols R, Huerta R, Ferreres J, Calabuig M, Juan M, Ezquer C, Colomina J, Blasco ML. Carbonell N, et al. Among authors: ferreres j. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01782-19. doi: 10.1128/AAC.01782-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31658972 Free PMC article. No abstract available.
Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway.
García-Laorden MI, Hernández-Brito E, Muñoz-Almagro C, Pavlovic-Nesic S, Rúa-Figueroa I, Briones ML, Rajas O, Borderías L, Payeras A, Lorente L, Freixinet J, Ferreres J, Obando I, González-Quevedo N, Rodríguez de Castro F, Solé-Violán J, Rodríguez-Gallego C. García-Laorden MI, et al. Among authors: ferreres j. J Clin Immunol. 2020 Jan;40(1):203-210. doi: 10.1007/s10875-019-00714-4. Epub 2019 Dec 11. J Clin Immunol. 2020. PMID: 31828694 Free PMC article.
Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia.
Matas-Nadal C, Malvehy J, Ferreres JR, Boada A, Bodet D, Segura S, Salleras M, Azon A, Bel-Pla S, Bigata X, Campoy A, Curcó N, Dalmau J, Formigon M, Gonzalez A, Just M, Llistosella E, Nogues ME, Pedragosa R, Pujol JA, Sabat M, Smandia JA, Zaballos P, Puig S, Martí RM. Matas-Nadal C, et al. Among authors: ferreres jr. Int J Dermatol. 2019 May;58(5):577-581. doi: 10.1111/ijd.14334. Epub 2018 Dec 13. Int J Dermatol. 2019. PMID: 30548854
Serum total antioxidant capacity during the first week of sepsis and mortality.
Lorente L, Martín MM, Pérez-Cejas A, Abreu-González P, López RO, Ferreres J, Solé-Violán J, Labarta L, Díaz C, Palmero S, Jiménez A. Lorente L, et al. Among authors: ferreres j. J Crit Care. 2018 Oct;47:139-144. doi: 10.1016/j.jcrc.2018.06.025. Epub 2018 Jun 30. J Crit Care. 2018. PMID: 29981999
Sustained Low Serum Substance P Levels in Non-Surviving Septic Patients.
Lorente L, Martín MM, Pérez-Cejas A, Ferreres J, Solé-Violán J, Labarta L, Díaz C, Jiménez A. Lorente L, et al. Among authors: ferreres j. Int J Mol Sci. 2017 Jul 15;18(7):1531. doi: 10.3390/ijms18071531. Int J Mol Sci. 2017. PMID: 28714876 Free PMC article.
Association between DNA and RNA oxidative damage and mortality in septic patients.
Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Ortiz-López R, Ferreres J, Solé-Violán J, Labarta L, Díaz C, Palmero S, Jiménez A. Lorente L, et al. Among authors: ferreres j. J Crit Care. 2019 Dec;54:94-98. doi: 10.1016/j.jcrc.2019.08.008. Epub 2019 Aug 5. J Crit Care. 2019. PMID: 31401543
Lower mitochondrial dysfunction in survivor septic patients with mitochondrial DNA haplogroup JT.
Lorente L, Martín MM, López-Gallardo E, Ferreres J, Solé-Violán J, Labarta L, Díaz C, Jiménez A, Montoya J, Ruiz-Pesini E. Lorente L, et al. Among authors: ferreres j. Enferm Infecc Microbiol Clin. 2018 Nov;36(9):539-543. doi: 10.1016/j.eimc.2017.08.011. Epub 2017 Oct 18. Enferm Infecc Microbiol Clin. 2018. PMID: 29054538 English, Spanish.
36 results
Jump to page
Feedback